NO20040775L - Oftalmisk sammensetning som innbefatter et askomycin - Google Patents

Oftalmisk sammensetning som innbefatter et askomycin

Info

Publication number: NO20040775L
Authority: NO; Norway
Prior art keywords: ascomycin; composition including; ophthalmic composition; ophthalmic; composition
Prior art date: 2001-08-23

Application number

NO20040775A

Other languages

English (en)

Norwegian (no)

Inventor

Michelle Pik-Han Wong

Kasey Jon Minick

Maggy Babiole Saunier

Jean-Claude Bizec

Andrea Fetz

Christian Schoch

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-23

Filing date

2004-02-17

Publication date

2004-02-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23219986&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20040775(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-02-17 Application filed by Novartis Ag filed Critical Novartis Ag

2004-02-17 Publication of NO20040775L publication Critical patent/NO20040775L/no

Links

ZDQSOHOQTUFQEM-PKUCKEGBSA-N ascomycin Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C\C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](O)[C@H](OC)C1 ZDQSOHOQTUFQEM-PKUCKEGBSA-N 0.000 title 1
ZDQSOHOQTUFQEM-XCXYXIJFSA-N ascomycin Natural products CC[C@H]1C=C(C)C[C@@H](C)C[C@@H](OC)[C@H]2O[C@@](O)([C@@H](C)C[C@H]2OC)C(=O)C(=O)N3CCCC[C@@H]3C(=O)O[C@H]([C@H](C)[C@@H](O)CC1=O)C(=C[C@@H]4CC[C@@H](O)[C@H](C4)OC)C ZDQSOHOQTUFQEM-XCXYXIJFSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO20040775A 2001-08-23 2004-02-17 Oftalmisk sammensetning som innbefatter et askomycin NO20040775L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US31444801P	2001-08-23	2001-08-23
PCT/EP2002/009408 WO2003017990A2 (en)	2001-08-23	2002-08-22	Ophthalmic composition comprising an ascomycin

Publications (1)

Publication Number	Publication Date
NO20040775L true NO20040775L (no)	2004-02-17

Family

ID=23219986

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040775A NO20040775L (no)	2001-08-23	2004-02-17	Oftalmisk sammensetning som innbefatter et askomycin

Country Status (27)

Country	Link
US (2)	US20030050255A1 (es)
EP (1)	EP1420787B8 (es)
JP (1)	JP2005501105A (es)
KR (2)	KR20100089108A (es)
CN (1)	CN100366251C (es)
AR (1)	AR035293A1 (es)
AT (1)	ATE452638T1 (es)
AU (1)	AU2002331172B2 (es)
BR (1)	BR0211972A (es)
CA (1)	CA2457034C (es)
CO (1)	CO5560568A2 (es)
DE (1)	DE60234840D1 (es)
EC (1)	ECSP044981A (es)
ES (1)	ES2337130T3 (es)
HU (1)	HUP0402396A3 (es)
IL (1)	IL160374A0 (es)
MX (1)	MXPA04001646A (es)
MY (1)	MY157377A (es)
NO (1)	NO20040775L (es)
NZ (1)	NZ531224A (es)
PE (1)	PE20030311A1 (es)
PL (1)	PL208685B1 (es)
PT (1)	PT1420787E (es)
RU (1)	RU2313344C2 (es)
TW (1)	TWI324925B (es)
WO (1)	WO2003017990A2 (es)
ZA (1)	ZA200400772B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7354574B2 (en)	2002-11-07	2008-04-08	Advanced Ocular Systems Limited	Treatment of ocular disease
BE1015610A3 (nl) *	2003-07-17	2005-06-07	Corrutech Nv	Verbeterde lijm en werkwijze voor het vervaardigen ervan.
US7083802B2 (en) *	2003-07-31	2006-08-01	Advanced Ocular Systems Limited	Treatment of ocular disease
CA2539324A1 (en)	2003-09-18	2005-03-31	Macusight, Inc.	Transscleral delivery
US7087237B2 (en) *	2003-09-19	2006-08-08	Advanced Ocular Systems Limited	Ocular solutions
US7083803B2 (en)	2003-09-19	2006-08-01	Advanced Ocular Systems Limited	Ocular solutions
JP4974903B2 (ja)	2005-02-09	2012-07-11	参天製薬株式会社	疾患または状態を処置するための液体処方物
AU2006270041B2 (en)	2005-07-18	2011-08-18	Minu, Llc	Enhanced ocular neuroprotection/neurostimulation
WO2007092620A2 (en)	2006-02-09	2007-08-16	Macusight, Inc.	Stable formulations, and methods of their preparation and use
PL2001466T3 (pl)	2006-03-23	2016-06-30	Santen Pharmaceutical Co Ltd	Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń
US8541426B2 (en) *	2007-07-11	2013-09-24	Pfizer Inc.	Pharmaceutical compositions and methods of treating dry eye disorders
KR20130097813A (ko)	2008-04-21	2013-09-03	오토노미, 인코포레이티드	귀 질환 및 병태를 치료하기 위한 귀 조제물
US11969501B2 (en)	2008-04-21	2024-04-30	Dompé Farmaceutici S.P.A.	Auris formulations for treating otic diseases and conditions
KR101534422B1 (ko)	2008-05-14	2015-07-09	오토노미, 인코포레이티드	귀 질환 치료를 위한 제어 방출형 코르티코스테로이드 조성물 및 방법
US8648119B2 (en)	2008-05-23	2014-02-11	Otonomy, Inc.	Controlled release immunomodulator compositions and methods for the treatment of otic disorders
US8846770B2 (en)	2008-06-18	2014-09-30	Otonomy, Inc.	Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
US8349353B2 (en)	2008-06-27	2013-01-08	Otonomy, Inc.	Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
WO2010011466A2 (en)	2008-06-27	2010-01-28	Otonomy, Inc.	Controlled-release cns modulating compositions and methods for the treatment of otic disorders
US8496957B2 (en)	2008-07-21	2013-07-30	Otonomy, Inc	Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
US8318817B2 (en)	2008-07-21	2012-11-27	Otonomy, Inc.	Controlled release antimicrobial compositions and methods for the treatment of otic disorders
JP5421366B2 (ja)	2008-07-21	2014-02-19	オトノミ―，インク．	制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法
US8399018B2 (en)	2008-07-21	2013-03-19	Otonomy, Inc.	Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
CA2751761A1 (en)	2008-10-22	2010-04-29	House Ear Institute	Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor
US9486405B2 (en)	2013-08-27	2016-11-08	Otonomy, Inc.	Methods for the treatment of pediatric otic disorders
EP4374861A3 (en)	2015-11-16	2024-08-07	MedinCell S.A.	A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
US11040004B2 (en)	2016-09-16	2021-06-22	Otonomy, Inc.	Otic gel formulations for treating otitis externa
JP7699426B2 (ja) *	2018-11-30	2025-06-27	ロート製薬株式会社	光線による障害からの細胞保護用眼科組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69115990T2 (de) *	1990-05-29	1996-05-30	Ocular Res Of Bonton Inc	Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
US5247076A (en) *	1991-09-09	1993-09-21	Merck & Co., Inc.	Imidazolidyl macrolides having immunosuppressive activity
EP0551626A1 (en) *	1991-12-19	1993-07-21	LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d.	Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5302584A (en) *	1992-10-13	1994-04-12	American Home Products Corporation	Carbamates of rapamycin
JPH06345646A (ja) *	1993-06-08	1994-12-20	Fujisawa Pharmaceut Co Ltd	ローション剤
ATE299017T1 (de) *	1994-10-26	2005-07-15	Novartis Pharma Gmbh	Arzneimittel
AR004480A1 (es) *	1995-04-06	1998-12-16	Amico Derin C D	Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
JP4221762B2 (ja) *	1997-04-11	2009-02-12	アステラス製薬株式会社	医薬組成物
CZ287497B6 (cs) *	1997-12-30	2000-12-13	Galena, A. S.	Topické oční přípravky s imunosupresivními látkami
AU777915B2 (en) *	1999-04-30	2004-11-04	Sucampo Ag	Use of macrolide compounds for the treatment of dry eye

2002
- 2002-08-21 TW TW091118911A patent/TWI324925B/zh not_active IP Right Cessation
- 2002-08-21 AR ARP020103137A patent/AR035293A1/es unknown
- 2002-08-22 AT AT02767419T patent/ATE452638T1/de active
- 2002-08-22 CA CA2457034A patent/CA2457034C/en not_active Expired - Fee Related
- 2002-08-22 KR KR1020107014068A patent/KR20100089108A/ko not_active Abandoned
- 2002-08-22 RU RU2004108463/15A patent/RU2313344C2/ru not_active IP Right Cessation
- 2002-08-22 MX MXPA04001646A patent/MXPA04001646A/es active IP Right Grant
- 2002-08-22 KR KR10-2004-7002458A patent/KR20040030157A/ko not_active Ceased
- 2002-08-22 PL PL367459A patent/PL208685B1/pl not_active IP Right Cessation
- 2002-08-22 DE DE60234840T patent/DE60234840D1/de not_active Expired - Lifetime
- 2002-08-22 MY MYPI20023102A patent/MY157377A/en unknown
- 2002-08-22 IL IL16037402A patent/IL160374A0/xx unknown
- 2002-08-22 AU AU2002331172A patent/AU2002331172B2/en not_active Ceased
- 2002-08-22 EP EP02767419A patent/EP1420787B8/en not_active Expired - Lifetime
- 2002-08-22 HU HU0402396A patent/HUP0402396A3/hu unknown
- 2002-08-22 NZ NZ531224A patent/NZ531224A/en not_active IP Right Cessation
- 2002-08-22 PE PE2002000808A patent/PE20030311A1/es not_active Application Discontinuation
- 2002-08-22 ES ES02767419T patent/ES2337130T3/es not_active Expired - Lifetime
- 2002-08-22 BR BR0211972-2A patent/BR0211972A/pt active Search and Examination
- 2002-08-22 CN CNB028164466A patent/CN100366251C/zh not_active Expired - Fee Related
- 2002-08-22 JP JP2003522510A patent/JP2005501105A/ja active Pending
- 2002-08-22 WO PCT/EP2002/009408 patent/WO2003017990A2/en not_active Ceased
- 2002-08-22 PT PT02767419T patent/PT1420787E/pt unknown
- 2002-08-23 US US10/227,086 patent/US20030050255A1/en not_active Abandoned
2004
- 2004-01-30 ZA ZA200400772A patent/ZA200400772B/en unknown
- 2004-02-17 NO NO20040775A patent/NO20040775L/no not_active Application Discontinuation
- 2004-02-18 EC EC2004004981A patent/ECSP044981A/es unknown
- 2004-02-18 CO CO04013810A patent/CO5560568A2/es not_active Application Discontinuation
2010
- 2010-11-30 US US12/955,950 patent/US20110071186A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1420787B8 (en)	2010-09-01
ES2337130T3 (es)	2010-04-21
US20030050255A1 (en)	2003-03-13
US20110071186A1 (en)	2011-03-24
WO2003017990A3 (en)	2003-08-28
HUP0402396A2 (hu)	2005-09-28
KR20100089108A (ko)	2010-08-11
EP1420787B1 (en)	2009-12-23
ZA200400772B (en)	2004-10-11
CA2457034A1 (en)	2003-03-06
AU2002331172B2 (en)	2005-12-01
CN100366251C (zh)	2008-02-06
DE60234840D1 (de)	2010-02-04
CN1545414A (zh)	2004-11-10
MY157377A (en)	2016-06-15
HUP0402396A3 (en)	2005-12-28
HK1065961A1 (en)	2005-03-11
ATE452638T1 (de)	2010-01-15
RU2004108463A (ru)	2005-05-10
KR20040030157A (ko)	2004-04-08
PL208685B1 (pl)	2011-05-31
NZ531224A (en)	2005-09-30
WO2003017990A2 (en)	2003-03-06
EP1420787A2 (en)	2004-05-26
IL160374A0 (en)	2004-07-25
MXPA04001646A (es)	2004-05-31
TWI324925B (en)	2010-05-21
CO5560568A2 (es)	2005-09-30
PE20030311A1 (es)	2003-05-08
PL367459A1 (en)	2005-02-21
JP2005501105A (ja)	2005-01-13
PT1420787E (pt)	2010-03-01
ECSP044981A (es)	2004-04-28
CA2457034C (en)	2010-07-27
AR035293A1 (es)	2004-05-05
BR0211972A (pt)	2004-09-21
RU2313344C2 (ru)	2007-12-27

Legal Events

Date	Code	Title	Description
2011-04-04	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20040775L (no)	2004-02-17	Oftalmisk sammensetning som innbefatter et askomycin
CY20162200002T2 (el)	2017-01-25	Αντιιικοι παραγοντες
DE60200746D1 (de)	2004-08-19	Kautschukzusammensetzung
DE60216493D1 (de)	2007-01-11	Intraokularlinse
NO20034176L (no)	2003-11-21	Pyrazolopyrimidiner som terapeutiske midler
NO20034177D0 (no)	2003-09-19	Pyrazolopyrimidiner som terapeutiske midler
NO20033572L (no)	2003-10-07	Viskoelastiske blandinger
FI20010694L (fi)	2002-10-04	Implantti
DE60311340T8 (de)	2007-10-31	Optischer Schalter
BRPI0313075A2 (pt)	2017-05-02	composições de vidro
DE10290365T1 (de)	2003-12-18	Gummizusammensetzung
NO20044092L (no)	2004-09-27	Oftalmisk sammensetning som innbefatter ascomycin
DE60212442D1 (de)	2006-07-27	Kautschukzusammensetzung
ATE459598T1 (de)	2010-03-15	Sulfonamidderivate
DE60322421D1 (de)	2008-09-04	Verbesserter brillenbügel
ITMO20010248A0 (it)	2001-12-12	Dilatometro ottico perfezionato
DE50307217D1 (de)	2007-06-21	Glaskörper
DK1451433T3 (da)	2006-07-17	Glassammensætning
NO20020533L (no)	2002-08-05	Lysbane
NO20043664L (no)	2004-09-01	Ny fremgangsmate
FR2832920B1 (fr)	2004-10-01	Nouvel implant intraoculaire accomodatif
DE60236587D1 (de)	2010-07-15	Latexzusammensetzung
FR2803922B1 (fr)	2002-04-05	Lentille ophtalmique
DK1445641T3 (da)	2008-02-04	Okulære linser
FR2825911B1 (fr)	2003-09-19	Implant cotyloidien